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Abstract
Polycomb group (PcG) proteins are essential regulators of epigenetic gene silencing and
development. The PcG protein enhancer of zeste homolog 2 (Ezh2) is a key component of
the Polycomb Repressive Complex 2 and is responsible for placing the histone H3 lysine 27
trimethylation (H3K27me3) repressive mark on the genome through its methyltransferase
domain. Ezh2 is highly conserved in vertebrates. We studied the role of ezh2 during devel-
opment of zebrafish with the use of a mutant allele (ezh2(sa1199), R18STOP), which has a
stop mutation in the second exon of the ezh2 gene. Two versions of the same line were
used during this study. The first and original version of zygotic ezh2(sa1199) mutants unex-
pectedly retained ezh2 expression in brain, gut, branchial arches, and eyes at 3 days post-
fertilization (dpf), as revealed by in-situ hybridization. Moreover, the expression pattern in
homozygous mutants was identical to that of wild types, indicating that mutant ezh2 mRNA
is not subject to nonsense mediated decay (NMD) as predicted. Both wild type and ezh2
mutant embryos presented edemas at 2 and 3 dpf. The line was renewed by selective
breeding to counter select the non-specific phenotypes and survival was assessed. In con-
trast to earlier studies on ezh2 mutant zebrafish, ezh2(sa1199) mutants survived until adult-
hood. Interestingly, the ezh2 mRNA and Ezh2 protein were present during adulthood (70
dpf) in both wild type and ezh2(sa1199) mutant zebrafish. We conclude that the ezh2
(sa1199) allele does not exhibit an ezh2 loss-of-function phenotype.
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Introduction
In biology in general and certainly in the field of zebrafish biology, there is a major interest to
understand how individual proteins contribute to development and tissue homeostasis. The
primary approach to achieve this goal is generating loss-of-function mutations in protein cod-
ing genes. Specific and inducible genome editing through site-directed mutagenesis by zinc
finger nucleases, TALENs, or CRISPR-Cas9 [1–3], are routine now, but these approaches are
still expensive and time consuming. Knockdown by morpholino treatment, on the other hand,
is a relatively quick assay to produce phenotypes; however, this approach requires rigorous
controls [4]. As much as 18% of morpholinos has been predicted to have off-target effects [5],
and in some cases morpholinos lead to p53-activation-related cell death [6]. Moreover, mor-
pholino effects persist no longer than about 5 days post-fertilization (dpf), and this makes stud-
ies on larval stages beyond 5 dpf virtually impossible. For reverse genetic screens, random
mutagenesis is favorable for efficiency and cost-effectiveness. Alkylating agents such as ENU
(N-ethyl-N-nitrosourea) and EMS (Ethyl methanesulfonate) have been used extensively in the
last decades due to their high in-vivo potency for random mutagenesis. The development of
the TILLING (Targeting Induced Local Lesions in Genomes) method at the start of the 2000s
[7] has revolutionized zebrafish functional genomics [8] by enabling larger and faster forward
and reverse genetics screens. The development of this method resulted in the Zebrafish Muta-
tion Project in the Wellcome Trust Sanger Institute [9], with extensive collaborative effort.
The project aimed to produce a complete set of mutant zebrafish lines for every protein-coding
gene. F3-generation embryos, spawned by heterozygous F2 generation in-crosses, were moni-
tored until 5 dpf for phenotypes. Mutants and carrier alleles from the Zebrafish Mutation Proj-
ect are publicly available [9].
Mutant alleles serve as a great tool to study (the impairment of) gene regulation during
embryonic development. Although every cell in an organism has the same DNA sequence,
cells (and tissues) gain different functions during development through regulation of gene
expression. Epigenetics is the field of biology which explains how covalent modifications on
the genome affect gene expression, and as a result, cellular function. Research on the function
of proteins involved in the epigenetic control of gene expression takes a crucial role in our
understanding of how correct development and tissue homeostasis proceed. The Polycomb
Group (PcG) proteins are essential transcriptional gene repressors which are highly conserved
in all vertebrates. PcG proteins function mainly in two Polycomb Repressive Complexes
(PRC): PRC1 and PRC2. PRC2 places the repressive histone H3 lysine 27 trimethylation
(H3K27me3) mark on the genome through the methyltransferase Ezh2. This mark recruits
PRC1, which is thought to stabilize the H3K27me3 mark through the mono-ubiquitylation of
histone H2A lysine 119 (H2AK119Ub1) by the RING family of E3 ubiquitin ligases. These two
interrelated functions of PRC1 and PRC2, in turn, cause compaction of DNA around histone
proteins, and are thought to impede transcription by limiting the RNA Polymerase II accessi-
bility to specific genes [10–12]. PcG mutations have received particular attention due to their
association with embryonic lethality and cancer in placentals [13]; therefore, correct character-
ization of PcG protein function is essential for treatment prospects in human diseases [14,15].
Within PRC2, the methyltransferase Ezh2 has been extensively studied for its catalytic activ-
ity. The Ezh2 protein has two domains, WD-binding (the WD40-repeat-containing domain)
and SET (the Su(var)3-9, Enhancer-of-zeste and Trithorax), which are also highly conserved
in vertebrates [16]. The WD-binding domain, located near the N-terminus (amino acids 39–
68 in zebrafish [16]) predominantly regulates the interaction between PRC2 components Eed
and Ezh2 [17,18]. The SET domain, located near the C-terminus (amino acids 626–747 in zeb-
rafish [16]) regulates the methyltransferase function of the Ezh2-PRC2 complex [19]. In mice,
ezh2(sa1199) mutant zebrafish display no phenotype
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Ezh2 knockout causes early embryonic lethality [20], therefore, its function has been investi-
gated through conditional tissue-specific knockouts [21–28]. According to the majority of
these studies, the functions of Ezh2 in mice can be summarized in three categories: Ezh2 is cru-
cial for normal cell proliferation in tissues, it regulates correct transcription of tissue specific
genes, and it contributes to correct tissue maintenance. For instance, Ezh2-overexpressing
hematopoietic stem cells that are transplanted into immune-compromised mice restore long-
term (blood) repopulation potential; stem cell exhaustion is thereby prevented [29]. Recently,
there is accumulating evidence for redundancy of Ezh1 in setting the H3K27me3 mark [30],
albeit with lower activity [31], that may prevent the full PRC2-null phenotype as a result of tis-
sue specific Ezh2 knockout. Tissue specific knockout of Eed, another essential subunit of the
PRC2 complex, on the other hand, prevents formation of the PRC2 complex and results in
complete loss of the H3K27me3 mark [32].
Early zebrafish development is highly synchronized under laboratory conditions, rendering this
model organism suitable for epigenetic research. Moreover, the possibility to obtain 200–600
embryos at the same stage of development (per clutch) facilitates the sampling process for experi-
mental techniques in epigenetics, which require large numbers of cells/donors. Studies on the estab-
lishment of epigenetic marks during early zebrafish development have given important insights on
how the repressive functions of PcG proteins instruct developmental programs before tissue specifi-
cation [33–35]. However, how the PRC2 complex regulates zebrafish organogenesis and tissue
homeostasis is not completely understood. Therefore, studying PcG function in (mutant) zebrafish
after tissue specification can shed light on epigenetic regulation of tissue homeostasis.
We previously studied the loss of ezh2 during early zebrafish development with the mutant
allele ezh2(hu5670), which presents a nonsense mutation upstream of the methyltransferase
domain [16]. Accordingly, maternal-zygotic ezh2(hu5670) mutant embryos form a normal body
plan despite major differences in gene expression during the early hours of development com-
pared to wild type embryos and die at 2 dpf exhibiting a range of phenotypes, including loss of
myocardial integrity and suspected terminal differentiation defects in liver and pancreas. Zygotic
ezh2(hu5670) mutants show no apparent phenotype at 5 dpf, but die around 11 dpf with intesti-
nal and hepatic maintenance defects [36]. Similarly, zygotic ezh2(ul2) nonsense mutants gener-
ated by Dupret and colleagues [37] with the use of TALENs technology [3] show intestinal and
pancreatic maintenance defects and lethality at 12 dpf. Moreover, these ezh2(hu5670) and ezh2
(ul2) mutants present reduced H3K27me3 levels. Overall, these key studies support an essential
role for Ezh2 in the epigenetic control of tissue maintenance and survival in zebrafish.
The study described here, aimed to investigate the effect of the loss of zygotic ezh2 expres-
sion during zebrafish development. In an attempt to further our insight on Ezh2 function, the
mutant allele ezh2(sa1199) generated by the Zebrafish Mutation Project was studied. From our
observations on the development and survival of ezh2(sa1199) embryos, the original line pro-
vided had background mutations, displaying lethality around 2 dpf and a non-specific edema
phenotype in mutants and wild types alike. We subsequently obtained another ezh2(sa1199)
line in which background mutations were eliminated by selective breeding. Unexpectedly, in
these mutants, no embryonic or larval phenotypes were observed, and the fish survived until
adulthood. We conclude that the ezh2(sa1199) nonsense mutant line does not present a loss-
of-function phenotype.
Materials and methods
Zebrafish husbandry and strains
All adult fish were maintained under standard conditions in a 14:10 light/dark cycle. Embryos
were reared in E3 medium at 28.5˚C [38] and staged following Kimmel et al. [39]. Two
ezh2(sa1199) mutant zebrafish display no phenotype
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different versions of the ezh2(sa1199) nonsense mutant allele (R18STOP, CTGGAGGCG
GC>TGAGTGAAGTC) were obtained from the Zebrafish Mutation Project [9], through Zebra-
fish International Resource Center. Mutant embryos were generated by in-crossing heterozy-
gous carriers. Adult lines were renewed and maintained by out-crossing the carrier line with
wild type Tubingen Long Fin (TLF) adults. European animal welfare laws and protocols were
strictly followed and approved after ethical testing by Central Committee for Animal Experi-
mentation (CCD) of the Netherlands in all experimental procedures.
Genotyping
Embryos (2–3 dpf) were briefly anesthetized in 2-phenoxyethanol (0.1% v/v) and their caudal
fins were clipped with a clean microsurgical blade. Individual fin-clips were lysed in 25 mM
NaOH and 0.2 mM EDTA at 95˚C and subsequently neutralized with an equal volume of 40 mM
Tris-HCl (pH predicted to be ~5). Three different genotyping methods were developed. For
amplification prior to Sanger sequencing, forward (5’-CATGGACATCTTTGGGTCCT-
3’) and reverse (5’-ACACACATGCAACTGGACTC-3’) primers were used. Allele
specific genotyping was done by combining a common forward primer (5’-AGATGTG
CACTCCTACGTTTGATAC-3’) with reverse primers that differentially
detect mutant (5’-GCATGTACTCAGACTTCACTAAC-3’) and wild type (5’-GCATG
TACTCAGACTTCACTAGC-3’) alleles, respectively, allowing 1 mismatch (in bold). The muta-
tion site is underlined. The third method applied a PCR amplification (forward 5’-ATGGG
ATTGACCGGGAGGAAATC-3’, reverse 5’-CTCTCTGGTTCCACGCAAGGAG-3’) fol-
lowed by enzymatic digestion with HphI; due to the C>T mutation, the mutant allele gains a
HphI restriction site, while the PCR product of the wild type allele remains uncut upon HphI
incubation. All primers flanked the mutation site in exon 2.
Whole mount in-situ hybridization
Embryos (3 dpf) were fixed in 4% paraformaldehyde in PBS (w/v) overnight at 4˚C, and whole
mount in-situ hybridization was performed as previously described [16]. The stained embryos
were mounted in 3% methylcellulose in water (w/v). The mounted embryos were covered with
a thin layer of PBST during stereo-microscopic (Leica MZ FLIII) imaging.
Survival assay
Embryos (3 dpf) were genotyped by a combination of PCR and HphI digestion as described
above. Wild-type (N = 18) and mutant (N = 21) larvae were transferred to the juvenile hus-
bandry system in separate tanks at 5 dpf. Dead larvae were collected daily to assess survival.
Quantitative real time PCR
Wild type (N = 2) and ezh2(sa1199) mutant (N = 2) adult siblings at 70 dpf were mechanically
homogenized in TRIzol (Thermo Fisher) and total RNA was isolated as described elsewhere
[40]. Total RNA was reverse transcribed with Superscript III (Invitrogen, 18080093) and poly-
dT primers. Standard qPCR was performed with the use of SYBR Green (iQ SYBR Green
Supermix, BioRad, 1708880) to detect mRNA levels of ezh1 and ezh2, relative to reference
genes β-actin and ef1α in technical triplicates. RT-qPCR primers are shown in S1 Table.
Western blotting
Adult (70 dpf) wild type and mutant siblings of the ezh2(sa1199) allele were sacrificed in
2-phenoxyethanol (0.2% v/v). Individual fish were decapitated and the body was lysed in
ezh2(sa1199) mutant zebrafish display no phenotype
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protein lysis buffer (50mM Tris pH 7.5, 150mM NaCl, 1% NP-40, 0.1% sodium deoxycholate,
Roche protease inhibitor cocktail). After homogenization, 30 μg protein sample was loaded on
a 12% SDS-PAGE gel. Fixed larval (7 dpf) wild type and mutant siblings of the ezh2(sa1199)
allele were lysed in 50 μl RIPA buffer (20 mM Tris-HCl pH 8.8, 150 mM NaCl, 1% NP-40,
0.5% Sodium deoxycholate) in pools of 5, and SDS was added to reach a final concentration of
2% (v/v). Protein samples were incubated in a thermomixer at 600 rpm for 20 minutes at
100˚C, followed by 2 hours at 80˚C. Samples were subsequently sonicated 2 times for 15 sec-
onds (Pico Bioruptor), cleared by centrifugation at 4˚C at 16,000 g for 12 minutes, and loaded
on a 4–15% gradient protein gel (Biorad, Mini-Protean TGX). Adult (70 dpf) and larval (7 dpf)
SDS-PAGE bands were transferred onto nitrocellulose membranes for anti-Ezh2 (Cell Signal-
ing Technologies, Ezh2 (Cell Signaling Technology, D2C9 XP), anti-β-actin (Sigma), and anti-
H3K27me3 (Millipore) antibody staining. After incubation with the secondary antibody (Life
Technologies, Alexa Fluor 800), the signal was visualized via Odyssey CLx Western Blot Detec-
tion System, and the anti-H3K27me3 bands were quantified by the gel analysis tool on Image J
software, relative to anti-β-actin loading control.
Assessment of water quality
System water samples (12–15 ml) from erroneous and correct piping were collected and acidi-
fied with 1–5% (v/v) HNO3 to keep metals in solution. Aluminum (Al), Calcium (Ca), Cad-
mium (Cd), Copper (Cu), Iron (Fe), Potassium (K), Magnesium (Mg), Manganese (Mn),
Sodium (Na), Phosphorus (P), Sulfur (S), Silicium (Si), and Zinc (Zn) absorptions were mea-
sured by inductively coupled plasma—optical emission spectrometry (ICP-OES). Concentra-
tions were calculated in parts per billion (ppb) and a ratio of erroneous and correct piping was
taken for comparison of element concentrations.
Results
To study the loss of ezh2 during zebrafish development, we scanned the Zebrafish Mutation
Project [9] for available loss-of-function mutations for this gene. We identified the ezh2
(sa1199) allele, which has a nonsense mutation that causes a truncation at arginine 18
(R18STOP) in exon 2. Nonsense mutations in the same gene are predicted to show allelic het-
erogeneity, i.e. displaying similar phenotypes. This third mutant allele could complement the
published mutant alleles ezh2(ul2) [36] and ezh2(hu5670) [16], which have nonsense muta-
tions at amino acids 60 and 592 (Fig 1A), respectively.
Genotyping ezh2(sa1199) mutants
Next to Sanger sequencing, we developed two genotyping methods to distinguish wild type, het-
erozygous, and homozygous mutant siblings. The ezh2 mutant embryos were generated by in-
crossing ezh2(sa1199) heterozygous adults. The two methods, allele-specific PCR amplification of
the region flanking the mutation site and PCR amplification combined with restriction digestion
by the enzyme HphI, both confirmed the predicted genotypes (Fig 1B). Allele specific PCR geno-
typing was verified by Sanger sequencing (Fig 1C). By all methods, ezh2(sa1199) sibling geno-
types were confirmed to be in line with the predicted Mendelian ratio after an in-cross (Fig 1D).
The ezh2(sa1199) zebrafish line expresses ezh2 and shows a non-specific
phenotype
In mutant alleles such as ezh2(sa1199), which translate into a stop codon, nonsense mediated
decay (NMD) mechanisms are predicted to operate at the mRNA level [41–43]. Therefore, we
ezh2(sa1199) mutant zebrafish display no phenotype
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predicted little to no ezh2 expression in ezh2(sa1199) mutant embryos by 3 dpf. To test this,
we performed whole mount in-situ hybridization (WISH) for expression of ezh2 mRNA in
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ezh2(sa1199) mutant embryos. Surprisingly, ezh2 mRNA expression patterns were highly
comparable between wild types, heterozygotes, and homozygous mutant embryos at 3 dpf (Fig
2A, left panel). In all embryos tested, ezh2 expression was visible in brain, eyes, branchial
arches, and gut. This observation contrasts strongly with earlier studies [16,36,37], where ezh2
expression in mutant embryos is severely suppressed at 3 dpf. Indeed, WISH on zygotic ezh2
(hu5670) in-crossed siblings showed that ezh2 expression is decreased in heterozygotes and
about undetectable in mutants by 3 dpf (Fig 2A, right panel).
During the development of ezh2(sa1199) siblings, severe abnormalities were seen, both in
homozygous mutant and in wild type embryos. Brain and heart edemas were present, with
defects in blood circulation and spinal curvature throughout clutches of embryos from differ-
ent parents (Fig 2B). This phenotype affected survival of the embryos. Although increased
lethality was observed amongst mutants as of 2 dpf, embryos from all genotypes showed
decreased survival. Swim bladder development was also affected, which might have contrib-
uted to lethality in larvae after 5 dpf. Zebrafish larvae which cannot inflate their swim bladders
cannot rise to the water surface to reach good quality feed, and eventually die during early lar-
val stages.
One may predict that lines derived from ENU-mutagenized libraries will retain background
mutations. The effect of these possible mutations on embryonic phenotypes can be circum-
vented by selectively breeding the adult carrier pairs which produce healthy embryos, and sub-
sequently out-crossing them with wild types. Such an ezh2(sa1199) line was obtained from the
Wellcome Trust Sanger Institute.
Out-crossed ezh2(sa1199) mutants show no lethality
During the development of out-crossed ezh2(sa1199) embryos, no non-specific phenotypes or
edemas were observed. Next, survival of the out-crossed line was assessed by comparing the
viability of wild type and mutant larvae. Surprisingly, no lethality in homozygous mutants
occurred, as the fish successfully reached adulthood (Fig 3A). This observation contrasts
strongly with recent data on zygotic ezh2(sa1199), ezh2(hu5670), and ezh2(ul2) mutants,
which survive on average for 7, 11, and 12 days, respectively [44,36,37].
By the time the ezh2(sa1199) line reached adulthood, all observed mutants developed an
abnormal jaw structure; the mutant fish could not close their mouth, while jaws of wild type
siblings were normal (Fig 3B). Concurrently, during a routine water quality check for various
elements, a higher (33.46 ppb) than normal (1 ppb) copper concentration was measured in the
system where wild type and mutant zebrafish in the ezh2(sa1199) background were housed
(S1A Fig). High copper concentrations are known to cause developmental defects and mortal-
ity, particularly due to cellular stress of ion transporting cells in the gill epithelium in zebrafish
[45] and tilapia [46]. Gills develop from the pharyngeal arches which house craniofacial cell
precursors [47]. Initially, because the open mouth phenotype was detected only in the mutants,
we suspected a delayed Polycomb group protein-related phenotype. Mice with conditional
Ezh2 knockout [48] and zebrafish mutant for rnf2, the catalytic subunit of PRC1 [49], do have
craniofacial abnormalities. However, whether the craniofacial phenotype seen in homozygous
mutants is related to ezh2 loss is inconclusive.
Existing literature and earlier observations in our laboratory strongly favor the notion that
ezh2 mutant zebrafish have a Polycomb group protein-related phenotype and do not survive
until adulthood. Yet, the observation that ezh2 mRNA may be exempt from nonsense medi-
ated decay in ezh2(sa1199) mutants (Fig 2A, left panel) prompted the assessment of Ezh2
mRNA and protein levels in 70 dpf wild type and ezh2 mutant adult zebrafish. We euthanized
and decapitated ezh2(sa1199) mutant and wild type individuals and lysed the body for real-
ezh2(sa1199) mutant zebrafish display no phenotype
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time quantitative PCR analysis of ezh1 and ezh2 mRNA (Fig 3C) and Western blot analysis of
Ezh2 protein (Fig 3D, upper panel, S1B Fig). No significant differences were detected in ezh1
and ezh2 mRNA levels between ezh2(sa1199) mutants and wild types. Ezh2 protein was detect-
able in the body in all samples, regardless of genotype (Fig 3D, upper panel), whereas it was
absent in the head of wild types and mutants (S1B Fig). Interestingly, at 7 dpf, levels of the
repressive H3K27me3 mark were decreased 41.8% in ezh2(sa1199) mutant larvae compared to
wild types (Fig 3D, lower panel, S1C Fig). The anti-Ezh2 antibody utilized for this experiment
is known to be specific for zebrafish and is absent in maternal-zygotic ezh2 mutants (S1D Fig)
[16,50]. Thus, in ezh2(sa1199) mutants, ezh2 mRNA is not subjected to NMD and despite the
presence of an R18STOP mutation, Ezh2 protein is still translated.
expression pattern; they are phenotypically comparable to wild types and have the same spatiotemporal ezh2 expression pattern. Right
panel. Wild type siblings (top) show similar ezh2 expression to ezh2(sa1199) in-cross embryos (white arrowheads). Heterozygotes
(middle) show decreased expression, and ezh2 is barely detectable in ezh2(hu5670) mutants (bottom). Scale bar: 500 μm. Numbers
indicate the number of embryos displaying the shown expression pattern per total number of embryos tested. B. Left panel shows
normal wild type and mutant embryos at 3 and 2 dpf, respectively. The right panel shows 2 and 3 dpf wild type and mutant embryos,
respectively, with yolk sac, heart, and brain edemas (white arrowheads) and spinal curvatures (black arrowheads).
https://doi.org/10.1371/journal.pone.0210217.g002
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assay was performed with ezh2(sa1199) in-crossed wild type (N = 18, blue line) and mutant (N = 21, orange line)
siblings until 46 dpf. Some larval lethality during raising was seen both in wild types and mutants. The graph indicates
that the survival of homozygous ezh2(sa1199) mutants is not significantly different from wild type siblings. B. Pictures
of wild type and mutant ezh2(sa1199) adult siblings. While wild types have normal jaws (left), adult ezh2(sa1199)
mutants (right) display an open mouth phenotype (black arrowhead). C. RT-qPCR measurement of ezh1 and ezh2
mRNA in ezh2(sa1199) adults. The (decapitated) body of 70 dpf wild type (blue) and mutant (orange) individuals were
lysed and the presence of ezh1 and ezh2 mRNA was quantified and normalized to the reference genes ß-actin and ef1a.
The ezh1 (p = 0.9509) and ezh2 (p = 0.1493) mRNA levels were not significantly altered in mutants. D. Ezh2 protein in
single 70 dpf adults and H3K27me3 in 7 dpf pooled larvae. The presence of Ezh2 was tested in wild type (N = 3, left)
and mutant (N = 4, right) bodies at 70 dpf, where Ezh2 expression persists (upper panel). At 7 dpf, mutant larvae
(right) show 41.8% decreased levels of the H3K27me3 mark compared to wild type (left) larvae (lower panel) and
relative to β-actin loading control. For each Western blot, representative bands were cropped from the same blot and
shown in boxes for clarity of presentation.
https://doi.org/10.1371/journal.pone.0210217.g003
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Discussion
This study aimed to investigate the effects of zygotic loss of ezh2 during zebrafish development.
Our hypothesis was that zygotic ezh2 mutant zebrafish would develop defects in tissue mainte-
nance and consequently die at early larval stages. This hypothesis was supported by our earlier
published research on zygotic ezh2(hu5670) mutants [36] and by Dupret and colleagues on the
ezh2(ul2) allele [37]. In zygotic ezh2(hu5670) and ezh2(ul2) mutants, larval intestines are
underdeveloped and cannot be maintained due to the loss of ezh2, followed by lethality around
10–12 dpf. We speculate that the ezh2(sa1199) stop mutation upstream of the WD-binding
multimerization domain might cause a (more severe or) earlier phenotype, due to the function
of the domain in PRC2 complex formation [17,18]. Monitoring the development of ezh2
(sa1199) mutants, we concluded that there were secondary problems in the embryos, such as
unexplained and non-specific edemas in wild types and mutants alike. The renewal of the line
by selective breeding, out-crosses with wild types, and screening against the non-specific phe-
notype eliminated these edemas in wild type and ezh2 mutant embryos alike. However, follow-
ing several experiments, we did not observe any ezh2 phenotype as seen and reported in
published work on the (maternal) zygotic ezh2(hu5670) and zygotic ezh2(ul2) mutant alleles
[16,36,37].
The ezh2(sa1199) line we first worked with showed multi-level problems regardless of
genotype, and were most likely caused by background mutations after random ENU muta-
genesis. The rate and frequency of mutations upon ENU treatment can be highly variable
and dependent on the experimental conditions [51]. Edemas in zebrafish have been associ-
ated with environmental [52] or morpholino-induced toxicity [53], loss of gene function
[54,55], lymphatic system and kidney failures [56,57], and they often coincide with tail cur-
vature [58]. We speculate that the lethality and edemas observed at 2 dpf relate to back-
ground mutations.
The selectively bred ezh2(sa1199) line, interestingly, survived into adulthood with no appar-
ent embryonic or larval phenotype. This observation contrasts with published research on the
ezh2(sa1199) allele: ezh2(sa1199) mutants showed decreased Ezh2 protein and H3K27me1/2/3
levels at 2 dpf, and lethality at 7 dpf [44]. Moreover, the loss of ezh2 affected the expression of
circadian clock genes [44]. Our results do not corroborate the abovementioned study, and
rather matches current observations made by the Wellcome Trust Sanger Institute, which indi-
cate no phenotype until 5 dpf for this allele during the preparation of this manuscript ([9],
https://www.sanger.ac.uk/sanger/Zebrafish_Zmpgene/ENSDARG00000010571#sa1199).
Although the ezh2(sa1199) mutants reached adulthood, they manifested an “open mouth”
phenotype. Craniofacial abnormalities can be caused by PcG mutations, amongst others
[47,48,49]. As these mutants were otherwise seemingly healthy adults, we concluded that the
‘open-mouth’ phenotype does not affect food intake.
When we detected abnormal water copper levels (resulting from a placement of copper
pipes) in the zebrafish system, we evaluated copper as a possible cause for craniofacial abnor-
malities in the ezh2(sa1199) mutant adults. Effects of copper exposure on zebrafish embryos
and adults have been studied by many research groups. In adult zebrafish, decreased oxidative
capacity in liver and gill are observed upon water copper exposure [59]. Importantly, disrup-
tion of copper metabolism in early development as opposed to overexposure leads to pharyn-
geal arch deformities [60,61]. These findings illustrate the possibility that copper intoxication
may have resulted in a jaw phenotype in this study. Further, the likelihood that ezh2(sa1199)
mutants are more sensitive to environmental toxicity than wild types, which could be caused
by lower H3K27me3 levels at 7 dpf, might explain the mutant-specific phenotype seen in this
study.
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Whole mount in-situ hybridization (WISH) for ezh2 in 3 dpf embryos, and RT-qPCR on 70
dpf adults show that there is no reduction in ezh2 mRNA levels in ezh2(sa1199) mutants.
Western blot analysis on 70 dpf mutant adults further indicates that Ezh2 protein is translated.
These two experiments were done in different ezh2(sa1199) lines from different age groups;
the WISH experiment at 3 dpf in the line with non-specific edemas, the latter 70 dpf experi-
ments in the line which survived until adulthood. We speculate similarities in the transcription
and translation patterns between these two different generations of the ezh2(sa1199) line.
Taken together, the results of the two experiments strongly suggest that the R18STOP muta-
tion in the ezh2(sa1199) allele does not result in a loss-of-function mutation, as ezh2 mRNA
and Ezh2 protein were both present in these ezh2 mutants.
There could be many reasons for a nonsense mutation to retain mRNA and protein expres-
sion. After transcription, NMD might be bypassed and a full-length protein might be trans-
lated, which could function just sub-optimally or normally [62]. In fact, many nonsense
mutations are capable of bypassing NMD, and are tolerant to loss of function by presently
unknown mechanisms [63–65]. Accumulating evidence suggests that nonsense mutations
close to the N-terminus might be more likely to bypass NMD; in some cases, translation can
be re-initiated at a downstream start codon [66,67]. In human cancer cells, NMD efficiency
drops to 35% when the premature termination codon lies in the first 200 nucleotides, as
opposed to 93% NMD efficiency for more downstream mutations [68]. The R18STOP muta-
tion of the ezh2(sa1199) allele is located at Ezh2 N-terminus, which is highly conserved
amongst vertebrates [16]. This conservation indicates high functionality and decreases the
likelihood of exon skipping or alternative splicing. Indeed, there are no documented zebrafish
ezh2 transcript variants which skip the transcription of the first two exons (Ensembl Release
92, April 2018).
According to our findings, the nonsense mutation in the ezh2(sa1199) allele is not in con-
cert with the presence of ezh2 mRNA and Ezh2 protein in these mutant zebrafish. This study
further emphasizes the importance of taking possible background and/or linked mutations
into account in mutagenesis screens, and their correlation with (non-specific) phenotypes.
Taken together, the presence of the Ezh2 mRNA and protein and the lack of a larval phenotype
in mutants indicates that the ezh2(sa1199) allele is not a suitable model to study loss of ezh2
function in zebrafish.
Supporting information
S1 Fig. Water quality measurements and Western blot analysis. A. Fold changes in element
concentrations (ppb) in the water system which housed ezh2(sa1199) zebrafish. During regular
water quality checks, Aluminum (Al), Calcium (Ca), Cadmium (Cd), Copper (Cu), Iron (Fe),
Potassium (K), Magnesium (Mg), Manganese (Mn), Sodium (Na), Phosphorus (P), Sulfur (S),
Silicium (Si), and Zinc (Zn) absorptions were measured and element concentrations were cal-
culated. The graph shows the ratio of element concentrations between erroneous and correct
piping. Erroneous piping in the water supply led to 33.46-fold higher than normal Copper
concentrations. During this time, an open mouth phenotype was observed specifically in ezh2
(sa1199) mutant adult zebrafish. B. Expression of Ezh2 protein in homozygous ezh2(sa1199)
mutants. The presence of Ezh2 (top panel) and β-actin (bottom panel) was tested by Western
blot analysis in wild type (ezh2+/+, N = 3, left) and mutant (ezh2sa1199/sa1199, N = 4, right) body,
intestine, and head of single fish at 70 dpf. Ezh2 expression persisted only in the head of wild
types and mutants. β-actin protein was used as a loading control. The figure shows the com-
plete Western blot which was shown in part in Fig 3D upper panel, and includes additional
intestinal samples which however were subject to autolysis, and head samples, which do not
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show Ezh2 expression. C. Western blot analysis in 7 dpf wild type (ezh2+/+) and mutant
(ezh2sa1199/sa1199) larvae depicting the presence of the H3K27me3 mark (upper panel). In
mutants, there is a 41.8% decrease in H3K27me3 levels, normalized against loading control β-
actin (lower panel). The figure shows the complete version of the Western blot analysis
depicted in Fig 3D lower panel (10 μl, right), with an additional dilution (5 μl, left). D. Western
blot analysis of Ezh2 and β-actin in 24 hours-post fertilization (hpf) wild type (ezh2+/+, N = 2)
and maternal-zygotic ezh2 mutant (MZezh2-/-, N = 2) embryos [16,50], demonstrating that the
antibody used in Fig 3D and S1B Fig is able to recognize the loss of the Ezh2 protein in estab-
lished Ezh2 mutations, which are subject to NMD.
(EPS)
S1 Table. List of RT-qPCR primers. Forward and reverse RT-qPCR primers for ezh1, ezh2,
ef1a, b-actin, used for the analysis of relative ezh1 and ezh2 expression in 70 dpf wild type and
ezh2(sa1199) mutant siblings.
(XLSX)
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